<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32887381</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Ubiquitin, Autophagy and Neurodegenerative Diseases.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2022</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells9092022</ELocationID><Abstract><AbstractText>Ubiquitin signals play various roles in proteolytic and non-proteolytic functions. Ubiquitin signals are recognized as targets of the ubiquitin-proteasome system and the autophagy-lysosome pathway. In autophagy, ubiquitin signals are required for selective incorporation of cargoes, such as proteins, organelles, and microbial invaders, into autophagosomes. Autophagy receptors possessing an LC3-binding domain and a ubiquitin binding domain are involved in this process. Autophagy activity can decline as a result of genetic variation, aging, or lifestyle, resulting in the onset of various neurodegenerative diseases. This review summarizes the selective autophagy of neurodegenerative disease-associated protein aggregates via autophagy receptors and discusses its therapeutic application for neurodegenerative diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Yoshihisa</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Basic Geriatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taguchi</LastName><ForeName>Katsutoshi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anatomy and Neurobiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Masaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anatomy and Neurobiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026901">Membrane Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C409460">OPTN protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C099718">SQSTM1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071456">Sequestosome-1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="C111567">parkin protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D026901" MajorTopicYN="N">Membrane Transport Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059748" MajorTopicYN="N">Proteolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071456" MajorTopicYN="N">Sequestosome-1 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025801" MajorTopicYN="N">Ubiquitin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054875" MajorTopicYN="N">Ubiquitination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">autophagy&#x2013;lysosome pathway</Keyword><Keyword MajorTopicYN="N">neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">ubiquitin</Keyword><Keyword MajorTopicYN="N">ubiquitin&#x2013;proteasome system</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32887381</ArticleId><ArticleId IdType="pmc">PMC7563958</ArticleId><ArticleId IdType="doi">10.3390/cells9092022</ArticleId><ArticleId IdType="pii">cells9092022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Galves M., Rathi R., Prag G., Ashkenazi A. Ubiquitin Signaling and Degradation of Aggregate-Prone Proteins. Trends Biochem. Sci. 2019;44:872&#x2013;884. doi: 10.1016/j.tibs.2019.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2019.04.007</ArticleId><ArticleId IdType="pubmed">31079890</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugger B.N., Dickson D.W. Pathology of Neurodegenerative Diseases. Cold Spring Harb. Perspect. Biol. 2017;9:a028035. doi: 10.1101/cshperspect.a028035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a028035</ArticleId><ArticleId IdType="pmc">PMC5495060</ArticleId><ArticleId IdType="pubmed">28062563</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon Y.T., Ciechanover A. The Ubiquitin Code in the Ubiquitin-Proteasome System and Autophagy. Trends Biochem. Sci. 2017;42:873&#x2013;886. doi: 10.1016/j.tibs.2017.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2017.09.002</ArticleId><ArticleId IdType="pubmed">28947091</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziv I., Matiuhin Y., Kirkpatrick D.S., Erpapazoglou Z., Leon S., Pantazopoulou M., Kim W., Gygi S.P., Haguenauer-Tsapis R., Reis N., et al. A perturbed ubiquitin landscape distinguishes between ubiquitin in trafficking and in proteolysis. Mol. Cell. Proteom. 2011;10:M111.009753. doi: 10.1074/mcp.M111.009753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M111.009753</ArticleId><ArticleId IdType="pmc">PMC3098606</ArticleId><ArticleId IdType="pubmed">21427232</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer A., Stelzmann R.A., Schnitzlein H.N., Murtagh F.R. An English translation of Alzheimer&#x2019;s 1907 paper, &#x201c;Uber eine eigenartige Erkankung der Hirnrinde&#x201d;. Clin. Anat. 1995;8:429&#x2013;431. doi: 10.1002/ca.980080612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ca.980080612</ArticleId><ArticleId IdType="pubmed">8713166</ArticleId></ArticleIdList></Reference><Reference><Citation>Duyckaerts C., Delatour B., Potier M.C. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009;118:5&#x2013;36. doi: 10.1007/s00401-009-0532-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0532-1</ArticleId><ArticleId IdType="pubmed">19381658</ArticleId></ArticleIdList></Reference><Reference><Citation>Esler W.P., Wolfe M.S. A portrait of Alzheimer secretases&#x2014;New features and familiar faces. Science. 2001;293:1449&#x2013;1454. doi: 10.1126/science.1064638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1064638</ArticleId><ArticleId IdType="pubmed">11520976</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer&#x2019;s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer&#x2019;s disease. Nat. Med. 1996;2:864&#x2013;870. doi: 10.1038/nm0896-864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0896-864</ArticleId><ArticleId IdType="pubmed">8705854</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe D.J., Hardy J. The amyloid hypothesis of Alzheimer&#x2019;s disease at 25 years. EMBO Mol. Med. 2016;8:595&#x2013;608. doi: 10.15252/emmm.201606210.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201606210</ArticleId><ArticleId IdType="pmc">PMC4888851</ArticleId><ArticleId IdType="pubmed">27025652</ArticleId></ArticleIdList></Reference><Reference><Citation>Thal D.R., Rub U., Orantes M., Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58:1791&#x2013;1800. doi: 10.1212/WNL.58.12.1791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.58.12.1791</ArticleId><ArticleId IdType="pubmed">12084879</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha S., Lieberburg I. Cellular mechanisms of beta-amyloid production and secretion. Proc. Natl. Acad. Sci. USA. 1999;96:11049&#x2013;11053. doi: 10.1073/pnas.96.20.11049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.20.11049</ArticleId><ArticleId IdType="pmc">PMC34239</ArticleId><ArticleId IdType="pubmed">10500121</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X., Crick S.L., Bu G., Frieden C., Pappu R.V., Lee J.M. Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc. Natl. Acad. Sci. USA. 2009;106:20324&#x2013;20329. doi: 10.1073/pnas.0911281106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0911281106</ArticleId><ArticleId IdType="pmc">PMC2787156</ArticleId><ArticleId IdType="pubmed">19910533</ArticleId></ArticleIdList></Reference><Reference><Citation>Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer&#x2019;s disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron. 2003;39:409&#x2013;421. doi: 10.1016/S0896-6273(03)00434-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(03)00434-3</ArticleId><ArticleId IdType="pubmed">12895417</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y.L., Wang N., Sun F.R., Cao X.P., Zhang W., Yu J.T. Tau in neurodegenerative disease. Ann. Transl. Med. 2018;6:175. doi: 10.21037/atm.2018.04.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2018.04.23</ArticleId><ArticleId IdType="pmc">PMC5994507</ArticleId><ArticleId IdType="pubmed">29951497</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosik K.S. The molecular and cellular biology of tau. Brain Pathol. 1993;3:39&#x2013;43. doi: 10.1111/j.1750-3639.1993.tb00724.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.1993.tb00724.x</ArticleId><ArticleId IdType="pubmed">8269082</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Mandelkow E. Tau in physiology and pathology. Nat. Rev. Neurosci. 2016;17:5&#x2013;21. doi: 10.1038/nrn.2015.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2015.1</ArticleId><ArticleId IdType="pubmed">26631930</ArticleId></ArticleIdList></Reference><Reference><Citation>Busciglio J., Lorenzo A., Yeh J., Yankner B.A. Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 1995;14:879&#x2013;888. doi: 10.1016/0896-6273(95)90232-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90232-5</ArticleId><ArticleId IdType="pubmed">7718249</ArticleId></ArticleIdList></Reference><Reference><Citation>Avila J. Tau phosphorylation and aggregation in Alzheimer&#x2019;s disease pathology. FEBS Lett. 2006;580:2922&#x2013;2927. doi: 10.1016/j.febslet.2006.02.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2006.02.067</ArticleId><ArticleId IdType="pubmed">16529745</ArticleId></ArticleIdList></Reference><Reference><Citation>Delacourte A., David J.P., Sergeant N., Bu&#xe9;e L., Wattez A., Vermersch P., Ghozali F., Fallet-Bianco C., Pasquier F., Lebert F., et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer&#x2019;s disease. Neurology. 1999;52:1158&#x2013;1165. doi: 10.1212/WNL.52.6.1158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.52.6.1158</ArticleId><ArticleId IdType="pubmed">10214737</ArticleId></ArticleIdList></Reference><Reference><Citation>De Calignon A., Polydoro M., Su&#xe1;rez-Calvet M., William C., Adamowicz D.H., Kopeikina K.J., Pitstick R., Sahara N., Ashe K.H., Carlson G.A., et al. Propagation of tau pathology in a model of early Alzheimer&#x2019;s disease. Neuron. 2012;73:685&#x2013;697. doi: 10.1016/j.neuron.2011.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.11.033</ArticleId><ArticleId IdType="pmc">PMC3292759</ArticleId><ArticleId IdType="pubmed">22365544</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda A., Mallory M., Sundsmo M., Honer W., Hansen L., Masliah E. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Am. J. Pathol. 1998;152:367&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1857971</ArticleId><ArticleId IdType="pubmed">9466562</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinreb P.H., Zhen W., Poon A.W., Conway K.A., Lansbury P.T., Jr. NACP, a protein implicated in Alzheimer&#x2019;s disease and learning, is natively unfolded. Biochemistry. 1996;35:13709&#x2013;13715. doi: 10.1021/bi961799n.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi961799n</ArticleId><ArticleId IdType="pubmed">8901511</ArticleId></ArticleIdList></Reference><Reference><Citation>Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839&#x2013;840. doi: 10.1038/42166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/42166</ArticleId><ArticleId IdType="pubmed">9278044</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman M.S., Lee V.M., Trojanowski J.Q. Nosology of Parkinson&#x2019;s disease: looking for the way out of a quagmire. Neuron. 2005;47:479&#x2013;482. doi: 10.1016/j.neuron.2005.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2005.07.021</ArticleId><ArticleId IdType="pubmed">16102530</ArticleId></ArticleIdList></Reference><Reference><Citation>Taguchi K., Watanabe Y., Tsujimura A., Tanaka M. Brain region-dependent differential expression of alpha-synuclein. J. Comp. Neurol. 2016;524:1236&#x2013;1258. doi: 10.1002/cne.23901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23901</ArticleId><ArticleId IdType="pubmed">26358191</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanis L. &#x3b1;-Synuclein in Parkinson&#x2019;s disease. Cold Spring Harb. Perspect. Med. 2012;2:a009399. doi: 10.1101/cshperspect.a009399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a009399</ArticleId><ArticleId IdType="pmc">PMC3281589</ArticleId><ArticleId IdType="pubmed">22355802</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiwara H., Hasegawa M., Dohmae N., Kawashima A., Masliah E., Goldberg M.S., Shen J., Takio K., Iwatsubo T. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 2002;4:160&#x2013;164. doi: 10.1038/ncb748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb748</ArticleId><ArticleId IdType="pubmed">11813001</ArticleId></ArticleIdList></Reference><Reference><Citation>Giasson B.I., Duda J.E., Murray I.V., Chen Q., Souza J.M., Hurtig H.I., Ischiropoulos H., Trojanowski J.Q., Lee V.M. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 2000;290:985&#x2013;989. doi: 10.1126/science.290.5493.985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.290.5493.985</ArticleId><ArticleId IdType="pubmed">11062131</ArticleId></ArticleIdList></Reference><Reference><Citation>Volpicelli-Daley L.A., Luk K.C., Patel T.P., Tanik S.A., Riddle D.M., Stieber A., Meaney D.F., Trojanowski J.Q., Lee V.M. Exogenous &#x3b1;-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron. 2011;72:57&#x2013;71. doi: 10.1016/j.neuron.2011.08.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.08.033</ArticleId><ArticleId IdType="pmc">PMC3204802</ArticleId><ArticleId IdType="pubmed">21982369</ArticleId></ArticleIdList></Reference><Reference><Citation>Luk K.C., Kehm V., Carroll J., Zhang B., O&#x2019;Brien P., Trojanowski J.Q., Lee V.M. Pathological &#x3b1;-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012;338:949&#x2013;953. doi: 10.1126/science.1227157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1227157</ArticleId><ArticleId IdType="pmc">PMC3552321</ArticleId><ArticleId IdType="pubmed">23161999</ArticleId></ArticleIdList></Reference><Reference><Citation>Taguchi K., Watanabe Y., Tsujimura A., Tatebe H., Miyata S., Tokuda T., Mizuno T., Tanaka M. Differential expression of alpha-synuclein in hippocampal neurons. PLoS ONE. 2014;9:e89327. doi: 10.1371/journal.pone.0089327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089327</ArticleId><ArticleId IdType="pmc">PMC3934906</ArticleId><ArticleId IdType="pubmed">24586691</ArticleId></ArticleIdList></Reference><Reference><Citation>Kordower J.H., Chu Y., Hauser R.A., Freeman T.B., Olanow C.W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson&#x2019;s disease. Nat. Med. 2008;14:504&#x2013;506. doi: 10.1038/nm1747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1747</ArticleId><ArticleId IdType="pubmed">18391962</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J.Y., Englund E., Holton J.L., Soulet D., Hagell P., Lees A.J., Lashley T., Quinn N.P., Rehncrona S., Bj&#xf6;rklund A., et al. Lewy bodies in grafted neurons in subjects with Parkinson&#x2019;s disease suggest host-to-graft disease propagation. Nat. Med. 2008;14:501&#x2013;503. doi: 10.1038/nm1746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1746</ArticleId><ArticleId IdType="pubmed">18391963</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Agnaf O.M., Salem S.A., Paleologou K.E., Cooper L.J., Fullwood N.J., Gibson M.J., Curran M.D., Court J.A., Mann D.M., Ikeda S., et al. Alpha-synuclein implicated in Parkinson&#x2019;s disease is present in extracellular biological fluids, including human plasma. FASEB J. 2003;17:1945&#x2013;1947. doi: 10.1096/fj.03-0098fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.03-0098fje</ArticleId><ArticleId IdType="pubmed">14519670</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang A., Lee H.J., Suk J.E., Jung J.W., Kim K.P., Lee S.J. Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions. J. Neurochem. 2010;113:1263&#x2013;1274. doi: 10.1111/j.1471-4159.2010.06695.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06695.x</ArticleId><ArticleId IdType="pubmed">20345754</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.J., Cho E.D., Lee K.W., Kim J.H., Cho S.G., Lee S.J. Autophagic failure promotes the exocytosis and intercellular transfer of &#x3b1;-synuclein. Exp. Mol. Med. 2013;45:e22. doi: 10.1038/emm.2013.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2013.45</ArticleId><ArticleId IdType="pmc">PMC3674407</ArticleId><ArticleId IdType="pubmed">23661100</ArticleId></ArticleIdList></Reference><Reference><Citation>Fussi N., H&#xf6;llerhage M., Chakroun T., Nyk&#xe4;nen N.P., R&#xf6;sler T.W., Koeglsperger T., Wurst W., Behrends C., H&#xf6;glinger G.U. Exosomal secretion of &#x3b1;-synuclein as protective mechanism after upstream blockage of macroautophagy. Cell Death Dis. 2018;9:757. doi: 10.1038/s41419-018-0816-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0816-2</ArticleId><ArticleId IdType="pmc">PMC6037700</ArticleId><ArticleId IdType="pubmed">29988147</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes B.B., DeVos S.L., Kfoury N., Li M., Jacks R., Yanamandra K., Ouidja M.O., Brodsky F.M., Marasa J., Bagchi D.P., et al. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc. Natl. Acad. Sci. USA. 2013;110:E3138&#x2013;E3147. doi: 10.1073/pnas.1301440110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1301440110</ArticleId><ArticleId IdType="pmc">PMC3746848</ArticleId><ArticleId IdType="pubmed">23898162</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao X., Ou M.T., Karuppagounder S.S., Kam T.I., Yin X., Xiong Y., Ge P., Umanah G.E., Brahmachari S., Shin J.H., et al. Pathological &#x3b1;-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science. 2016;353 doi: 10.1126/science.aah3374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aah3374</ArticleId><ArticleId IdType="pmc">PMC5510615</ArticleId><ArticleId IdType="pubmed">27708076</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C.C., Zhang Y., Umoh M.E., Vaughan S.W., Lorenzini I., Liu F., Sayegh M., Donlin-Asp P.G., Chen Y.H., Duong D.M., et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 2018;21:228&#x2013;239. doi: 10.1038/s41593-017-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F.B., Almeida S., Lopez-Gonzalez R. Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder. EMBO J. 2017;36:2931&#x2013;2950. doi: 10.15252/embj.201797568.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797568</ArticleId><ArticleId IdType="pmc">PMC5641681</ArticleId><ArticleId IdType="pubmed">28916614</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell N.E., Lambert-Smith I.A., Warraich S.T., Blair I.P., Saunders D.N., Hatters D.M., Yerbury J.J. Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions. Sci. Rep. 2015;5:13416. doi: 10.1038/srep13416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13416</ArticleId><ArticleId IdType="pmc">PMC4544019</ArticleId><ArticleId IdType="pubmed">26293199</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S., Stauffer J.E., Schulte D.J., Ravits J. Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants. Neurol. Clin. 2015;33:855&#x2013;876. doi: 10.1016/j.ncl.2015.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.012</ArticleId><ArticleId IdType="pmc">PMC4628785</ArticleId><ArticleId IdType="pubmed">26515626</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., Price D.L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995;14:1105&#x2013;1116. doi: 10.1016/0896-6273(95)90259-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90259-7</ArticleId><ArticleId IdType="pubmed">7605627</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z., Ryan V.H., Janke A.M., Burke K.A., Rhoads S.N., Zerze G.H., O&#x2019;Meally R., Dignon G.L., Conicella A.E., Zheng W., et al. Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. EMBO J. 2017;36:2951&#x2013;2967. doi: 10.15252/embj.201696394.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201696394</ArticleId><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Kim H.J. Prion-like Mechanism in Amyotrophic Lateral Sclerosis: are Protein Aggregates the Key? Exp. Neurobiol. 2015;24:1&#x2013;7. doi: 10.5607/en.2015.24.1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2015.24.1.1</ArticleId><ArticleId IdType="pmc">PMC4363329</ArticleId><ArticleId IdType="pubmed">25792864</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Guest W.C., Yanai A., Pokrishevsky E., O&#x2019;Neill M.A., Gibbs E., Semenchenko V., Yousefi M., Wishart D.S., Plotkin S.S., et al. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc. Natl. Acad. Sci. USA. 2011;108:16398&#x2013;16403. doi: 10.1073/pnas.1102645108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102645108</ArticleId><ArticleId IdType="pmc">PMC3182705</ArticleId><ArticleId IdType="pubmed">21930926</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura T., Watanabe S., Kaneko K., Yamanaka K., Nukina N., Furukawa Y. Intranuclear aggregation of mutant FUS/TLS as a molecular pathomechanism of amyotrophic lateral sclerosis. J. Biol. Chem. 2014;289:1192&#x2013;1202. doi: 10.1074/jbc.M113.516492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.516492</ArticleId><ArticleId IdType="pmc">PMC3887186</ArticleId><ArticleId IdType="pubmed">24280224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito D., Suzuki N. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS. Neurology. 2011;77:1636&#x2013;1643. doi: 10.1212/WNL.0b013e3182343365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182343365</ArticleId><ArticleId IdType="pmc">PMC3198978</ArticleId><ArticleId IdType="pubmed">21956718</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B., Ivanov P. Stress granules and neurodegeneration. Nat. Rev. Neurosci. 2019;20:649&#x2013;666. doi: 10.1038/s41583-019-0222-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-019-0222-5</ArticleId><ArticleId IdType="pmc">PMC6986315</ArticleId><ArticleId IdType="pubmed">31582840</ArticleId></ArticleIdList></Reference><Reference><Citation>Advani V.M., Ivanov P. Stress granule subtypes: An emerging link to neurodegeneration. Cell. Mol. Life Sci. 2020 doi: 10.1007/s00018-020-03565-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-020-03565-0</ArticleId><ArticleId IdType="pmc">PMC7668291</ArticleId><ArticleId IdType="pubmed">32500266</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan J.R., Parker R. Eukaryotic stress granules: The ins and outs of translation. Mol. Cell. 2009;36:932&#x2013;941. doi: 10.1016/j.molcel.2009.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2009.11.020</ArticleId><ArticleId IdType="pmc">PMC2813218</ArticleId><ArticleId IdType="pubmed">20064460</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr&#xf9; S., Coni P., Floris A., Littera R., Carcassi C., Sogos V., Brancia C. Reduced stress granule formation and cell death in fibroblasts with the A382T mutation of TARDBP gene: Evidence for loss of TDP-43 nuclear function. Hum. Mol. Genet. 2016;25:4473&#x2013;4483. doi: 10.1093/hmg/ddw276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw276</ArticleId><ArticleId IdType="pubmed">28172957</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Nicholson A.M., Sarkar M., Messing J., Purice M.D., Pottier C., Annu K., Baker M., Perkerson R.B., Kurti A., et al. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics. Neuron. 2017;95:808&#x2013;816.e809. doi: 10.1016/j.neuron.2017.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajroud-Driss S., Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis (ALS) Biochim. Biophys. Acta. 2015;1852:679&#x2013;684. doi: 10.1016/j.bbadis.2014.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2014.08.010</ArticleId><ArticleId IdType="pubmed">25193032</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z., Lim J., Wang Q., Purtell K., Wu S., Palomo G.M., Tan H., Manfredi G., Zhao Y., Peng J., et al. ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway. Autophagy. 2020;16:917&#x2013;931. doi: 10.1080/15548627.2019.1644076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1644076</ArticleId><ArticleId IdType="pmc">PMC7144840</ArticleId><ArticleId IdType="pubmed">31362587</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontali M., Novelletto A., Annesi G., Jodice C. CAG repeat instability, cryptic sequence variation and pathogeneticity: evidence from different loci. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 1999;354:1089&#x2013;1094. doi: 10.1098/rstb.1999.0464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.1999.0464</ArticleId><ArticleId IdType="pmc">PMC1692606</ArticleId><ArticleId IdType="pubmed">10434311</ArticleId></ArticleIdList></Reference><Reference><Citation>Saudou F., Humbert S. The Biology of Huntingtin. Neuron. 2016;89:910&#x2013;926. doi: 10.1016/j.neuron.2016.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.02.003</ArticleId><ArticleId IdType="pubmed">26938440</ArticleId></ArticleIdList></Reference><Reference><Citation>Yushchenko T., Deuerling E., Hauser K. Insights into the Aggregation Mechanism of PolyQ Proteins with Different Glutamine Repeat Lengths. Biophys. J. 2018;114:1847&#x2013;1857. doi: 10.1016/j.bpj.2018.02.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2018.02.037</ArticleId><ArticleId IdType="pmc">PMC5937114</ArticleId><ArticleId IdType="pubmed">29694863</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejia R.O.S., Friedlander R.M. Caspases in Huntington&#x2019;s disease. Neurosci. Rev. J. 2001;7:480&#x2013;489. doi: 10.1177/107385840100700604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/107385840100700604</ArticleId><ArticleId IdType="pubmed">11765125</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherzinger E., Lurz R., Turmaine M., Mangiarini L., Hollenbach B., Hasenbank R., Bates G.P., Davies S.W., Lehrach H., Wanker E.E. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell. 1997;90:549&#x2013;558. doi: 10.1016/S0092-8674(00)80514-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80514-0</ArticleId><ArticleId IdType="pubmed">9267034</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicchetti F., Lacroix S., Cisbani G., Valli&#xe8;res N., Saint-Pierre M., St-Amour I., Tolouei R., Skepper J.N., Hauser R.A., Mantovani D., et al. Mutant huntingtin is present in neuronal grafts in Huntington disease patients. Ann. Neurol. 2014;76:31&#x2013;42. doi: 10.1002/ana.24174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24174</ArticleId><ArticleId IdType="pubmed">24798518</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce M.M.P., Kopito R.R. Prion-Like Characteristics of Polyglutamine-Containing Proteins. Cold Spring Harb. Perspect. Med. 2018;8:a024257. doi: 10.1101/cshperspect.a024257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024257</ArticleId><ArticleId IdType="pmc">PMC5793740</ArticleId><ArticleId IdType="pubmed">28096245</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y., Tsujimura A., Taguchi K., Tanaka M. HSF1 stress response pathway regulates autophagy receptor SQSTM1/p62-associated proteostasis. Autophagy. 2017;13:133&#x2013;148. doi: 10.1080/15548627.2016.1248018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2016.1248018</ArticleId><ArticleId IdType="pmc">PMC5240838</ArticleId><ArticleId IdType="pubmed">27846364</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai H.C., Schuman E.M. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat. Rev. Neurosci. 2008;9:826&#x2013;838. doi: 10.1038/nrn2499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2499</ArticleId><ArticleId IdType="pubmed">18931696</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohl C., Dikic I. Cellular quality control by the ubiquitin&#x2013;proteasome system and autophagy. Science. 2019;366:818&#x2013;822. doi: 10.1126/science.aax3769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aax3769</ArticleId><ArticleId IdType="pubmed">31727826</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C.W., Jacobson A.D. Functions of the 19S complex in proteasomal degradation. Trends Biochem. Sci. 2013;38:103&#x2013;110. doi: 10.1016/j.tibs.2012.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2012.11.009</ArticleId><ArticleId IdType="pmc">PMC3557657</ArticleId><ArticleId IdType="pubmed">23290100</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecker S.H., Goldberg A.L., Mitch W.E. Protein degradation by the ubiquitin&#x2013;proteasome pathway in normal and disease states. J. Am. Soc. Nephrol. 2006;17:1807&#x2013;1819. doi: 10.1681/ASN.2006010083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2006010083</ArticleId><ArticleId IdType="pubmed">16738015</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N. Autophagy: Process and function. Genes Dev. 2007;21:2861&#x2013;2873. doi: 10.1101/gad.1599207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1599207</ArticleId><ArticleId IdType="pubmed">18006683</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabek N., Herman-Bachinsky Y., Buchsbaum S., Lewinson O., Haj-Yahya M., Hejjaoui M., Lashuel H.A., Sommer T., Brik A., Ciechanover A. The size of the proteasomal substrate determines whether its degradation will be mediated by mono- or polyubiquitylation. Mol. Cell. 2012;48:87&#x2013;97. doi: 10.1016/j.molcel.2012.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2012.07.011</ArticleId><ArticleId IdType="pubmed">22902562</ArticleId></ArticleIdList></Reference><Reference><Citation>Braten O., Livneh I., Ziv T., Admon A., Kehat I., Caspi L.H., Gonen H., Bercovich B., Godzik A., Jahandideh S., et al. Numerous proteins with unique characteristics are degraded by the 26S proteasome following monoubiquitination. Proc. Natl. Acad. Sci. USA. 2016;113:E4639&#x2013;E4647. doi: 10.1073/pnas.1608644113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1608644113</ArticleId><ArticleId IdType="pmc">PMC4987823</ArticleId><ArticleId IdType="pubmed">27385826</ArticleId></ArticleIdList></Reference><Reference><Citation>Komander D., Reyes-Turcu F., Licchesi J.D., Odenwaelder P., Wilkinson K.D., Barford D. Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep. 2009;10:466&#x2013;473. doi: 10.1038/embor.2009.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/embor.2009.55</ArticleId><ArticleId IdType="pmc">PMC2680876</ArticleId><ArticleId IdType="pubmed">19373254</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Fonts K., Davis C., Tomita T., Elsasser S., Nager A.R., Shi Y., Finley D., Matouschek A. The proteasome 19S cap and its ubiquitin receptors provide a versatile recognition platform for substrates. Nat. Commun. 2020;11:477. doi: 10.1038/s41467-019-13906-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13906-8</ArticleId><ArticleId IdType="pmc">PMC6981147</ArticleId><ArticleId IdType="pubmed">31980598</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley B.E., Kaiser S.E., Shaler T.A., Ng A.C., Hara T., Hipp M.S., Lage K., Xavier R.J., Ryu K.Y., Taguchi K., et al. Ubiquitin accumulation in autophagy-deficient mice is dependent on the Nrf2-mediated stress response pathway: A potential role for protein aggregation in autophagic substrate selection. J. Cell Biol. 2010;191:537&#x2013;552. doi: 10.1083/jcb.201005012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201005012</ArticleId><ArticleId IdType="pmc">PMC3003313</ArticleId><ArticleId IdType="pubmed">21041446</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y., Tanaka M. p62/SQSTM1 in autophagic clearance of a non-ubiquitylated substrate. J. Cell Sci. 2011;124:2692&#x2013;2701. doi: 10.1242/jcs.081232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.081232</ArticleId><ArticleId IdType="pubmed">21771882</ArticleId></ArticleIdList></Reference><Reference><Citation>Svenning S., Johansen T. Selective autophagy. Essays Biochem. 2013;55:79&#x2013;92. doi: 10.1042/bse0550079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bse0550079</ArticleId><ArticleId IdType="pubmed">24070473</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen T., Lamark T. Selective Autophagy: ATG8 Family Proteins, LIR Motifs and Cargo Receptors. J. Mol. Biol. 2020;432:80&#x2013;103. doi: 10.1016/j.jmb.2019.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2019.07.016</ArticleId><ArticleId IdType="pubmed">31310766</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatica D., Lahiri V., Klionsky D.J. Cargo recognition and degradation by selective autophagy. Nat. Cell Biol. 2018;20:233&#x2013;242. doi: 10.1038/s41556-018-0037-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-018-0037-z</ArticleId><ArticleId IdType="pmc">PMC6028034</ArticleId><ArticleId IdType="pubmed">29476151</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper J.W., Ordureau A., Heo J.M. Building and decoding ubiquitin chains for mitophagy. Nat. Rev. Mol. Cell Biol. 2018;19:93&#x2013;108. doi: 10.1038/nrm.2017.129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.129</ArticleId><ArticleId IdType="pubmed">29358684</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiba-Fukushima K., Inoshita T., Hattori N., Imai Y. Lysine 63-linked polyubiquitination is dispensable for Parkin-mediated mitophagy. J. Biol. Chem. 2014;289:33131&#x2013;33136. doi: 10.1074/jbc.C114.580944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C114.580944</ArticleId><ArticleId IdType="pmc">PMC4246074</ArticleId><ArticleId IdType="pubmed">25336644</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S., Vigi&#xe9; P., Youle R.J. Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance. Curr. Biol. 2018;28:R170&#x2013;R185. doi: 10.1016/j.cub.2018.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2018.01.004</ArticleId><ArticleId IdType="pmc">PMC7255410</ArticleId><ArticleId IdType="pubmed">29462587</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyano F., Okatsu K., Kosako H., Tamura Y., Go E., Kimura M., Kimura Y., Tsuchiya H., Yoshihara H., Hirokawa T., et al. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature. 2014;510:162&#x2013;166. doi: 10.1038/nature13392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13392</ArticleId><ArticleId IdType="pubmed">24784582</ArticleId></ArticleIdList></Reference><Reference><Citation>Cripps D., Thomas S.N., Jeng Y., Yang F., Davies P., Yang A.J. Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation. J. Biol. Chem. 2006;281:10825&#x2013;10838. doi: 10.1074/jbc.M512786200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M512786200</ArticleId><ArticleId IdType="pubmed">16443603</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrucelli L., Dickson D., Kehoe K., Taylor J., Snyder H., Grover A., De Lucia M., McGowan E., Lewis J., Prihar G., et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet. 2004;13:703&#x2013;714. doi: 10.1093/hmg/ddh083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddh083</ArticleId><ArticleId IdType="pubmed">14962978</ArticleId></ArticleIdList></Reference><Reference><Citation>Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Titani K., Ihara Y. Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron. 1993;10:1151&#x2013;1160. doi: 10.1016/0896-6273(93)90063-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(93)90063-W</ArticleId><ArticleId IdType="pubmed">8391280</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahara N., Murayama M., Mizoroki T., Urushitani M., Imai Y., Takahashi R., Murata S., Tanaka K., Takashima A. In vivo evidence of CHIP up-regulation attenuating tau aggregation. J. Neurochem. 2005;94:1254&#x2013;1263. doi: 10.1111/j.1471-4159.2005.03272.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03272.x</ArticleId><ArticleId IdType="pubmed">16111477</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson R.L., Laulagnier K., Miranda A.M., Fernandez M.A., Wolfe M.S., Sadoul R., Di Paolo G. Disruption of amyloid precursor protein ubiquitination selectively increases amyloid &#x3b2; (A&#x3b2;) 40 levels via presenilin 2-mediated cleavage. J. Biol. Chem. 2017;292:19873&#x2013;19889. doi: 10.1074/jbc.M117.818138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.818138</ArticleId><ArticleId IdType="pmc">PMC5712626</ArticleId><ArticleId IdType="pubmed">29021256</ArticleId></ArticleIdList></Reference><Reference><Citation>Rott R., Szargel R., Haskin J., Shani V., Shainskaya A., Manov I., Liani E., Avraham E., Engelender S. Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells. J. Biol. Chem. 2008;283:3316&#x2013;3328. doi: 10.1074/jbc.M704809200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M704809200</ArticleId><ArticleId IdType="pubmed">18070888</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.T., Wheeler T.C., Li L., Chin L.S. Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death. Hum. Mol. Genet. 2008;17:906&#x2013;917. doi: 10.1093/hmg/ddm363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm363</ArticleId><ArticleId IdType="pubmed">18065497</ArticleId></ArticleIdList></Reference><Reference><Citation>Tofaris G.K., Kim H.T., Hourez R., Jung J.W., Kim K.P., Goldberg A.L. Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway. Proc. Natl. Acad. Sci. USA. 2011;108:17004&#x2013;17009. doi: 10.1073/pnas.1109356108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1109356108</ArticleId><ArticleId IdType="pmc">PMC3193191</ArticleId><ArticleId IdType="pubmed">21953697</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin Y., Klucken J., Patterson C., Hyman B.T., McLean P.J. The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways. J. Biol. Chem. 2005;280:23727&#x2013;23734. doi: 10.1074/jbc.M503326200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M503326200</ArticleId><ArticleId IdType="pubmed">15845543</ArticleId></ArticleIdList></Reference><Reference><Citation>Rott R., Szargel R., Haskin J., Bandopadhyay R., Lees A.J., Shani V., Engelender S. &#x3b1;-Synuclein fate is determined by USP9X-regulated monoubiquitination. Proc. Natl. Acad. Sci. USA. 2011;108:18666&#x2013;18671. doi: 10.1073/pnas.1105725108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1105725108</ArticleId><ArticleId IdType="pmc">PMC3219120</ArticleId><ArticleId IdType="pubmed">22065755</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulherkar S.A., Sharma J., Jana N.R. The ubiquitin ligase E6-AP promotes degradation of alpha-synuclein. J. Neurochem. 2009;110:1955&#x2013;1964. doi: 10.1111/j.1471-4159.2009.06293.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06293.x</ArticleId><ArticleId IdType="pubmed">19645749</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.C., Huang W.C., Lin J.H., Kao T.J., Lin H.C., Lee K.H., Shen C.J., Chang W.C., Huang C.C. Znf179 E3 ligase-mediated TDP-43 polyubiquitination is involved in TDP-43- ubiquitinated inclusions (UBI) (+)-related neurodegenerative pathology. J. Biomed. Sci. 2018;25:76. doi: 10.1186/s12929-018-0479-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-018-0479-4</ArticleId><ArticleId IdType="pmc">PMC6223059</ArticleId><ArticleId IdType="pubmed">30404641</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida T., Tamaki Y., Ayaki T., Shodai A., Kaji S., Morimura T., Banno Y., Nishitsuji K., Sakashita N., Maki T., et al. CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS. Sci. Rep. 2016;6:19118. doi: 10.1038/srep19118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep19118</ArticleId><ArticleId IdType="pmc">PMC4707540</ArticleId><ArticleId IdType="pubmed">26751167</ArticleId></ArticleIdList></Reference><Reference><Citation>Hans F., Eckert M., von Zweydorf F., Gloeckner C.J., Kahle P.J. Identification and characterization of ubiquitinylation sites in TAR DNA-binding protein of 43 kDa (TDP-43) J. Biol. Chem. 2018;293:16083&#x2013;16099. doi: 10.1074/jbc.RA118.003440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.003440</ArticleId><ArticleId IdType="pmc">PMC6187624</ArticleId><ArticleId IdType="pubmed">30120199</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki K., Fujita T., Ozaki T., Kato C., Kurose Y., Sakamoto M., Kato S., Goto T., Itoyama Y., Aoki M., et al. NEDL1, a novel ubiquitin-protein isopeptide ligase for dishevelled-1, targets mutant superoxide dismutase-1. J. Biol. Chem. 2004;279:11327&#x2013;11335. doi: 10.1074/jbc.M312389200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M312389200</ArticleId><ArticleId IdType="pubmed">14684739</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang S., Ferrone M., Yang C., Jensen J.P., Tiwari S., Weissman A.M. The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA. 2001;98:14422&#x2013;14427. doi: 10.1073/pnas.251401598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.251401598</ArticleId><ArticleId IdType="pmc">PMC64697</ArticleId><ArticleId IdType="pubmed">11724934</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying Z., Wang H., Fan H., Zhu X., Zhou J., Fei E., Wang G. Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation. Hum. Mol. Genet. 2009;18:4268&#x2013;4281. doi: 10.1093/hmg/ddp380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp380</ArticleId><ArticleId IdType="pubmed">19661182</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat K.P., Yan S., Wang C.E., Li S., Li X.J. Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A. Proc. Natl. Acad. Sci. USA. 2014;111:5706&#x2013;5711. doi: 10.1073/pnas.1402215111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1402215111</ArticleId><ArticleId IdType="pmc">PMC3992696</ArticleId><ArticleId IdType="pubmed">24706802</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyuncu S., Saez I., Lee H.J., Gutierrez-Garcia R., Pokrzywa W., Fatima A., Hoppe T., Vilchez D. The ubiquitin ligase UBR5 suppresses proteostasis collapse in pluripotent stem cells from Huntington&#x2019;s disease patients. Nat. Commun. 2018;9:2886. doi: 10.1038/s41467-018-05320-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05320-3</ArticleId><ArticleId IdType="pmc">PMC6056416</ArticleId><ArticleId IdType="pubmed">30038412</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucchelli S., Marcuzzi F., Codrich M., Agostoni E., Vilotti S., Biagioli M., Pinto M., Carnemolla A., Santoro C., Gustincich S., et al. Tumor necrosis factor receptor-associated factor 6 (TRAF6) associates with huntingtin protein and promotes its atypical ubiquitination to enhance aggregate formation. J. Biol. Chem. 2011;286:25108&#x2013;25117. doi: 10.1074/jbc.M110.187591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.187591</ArticleId><ArticleId IdType="pmc">PMC3137084</ArticleId><ArticleId IdType="pubmed">21454471</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchberger A. From UBA to UBX: New words in the ubiquitin vocabulary. Trends Cell Biol. 2002;12:216&#x2013;221. doi: 10.1016/S0962-8924(02)02269-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0962-8924(02)02269-9</ArticleId><ArticleId IdType="pubmed">12062168</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters S., Marchbank K., Solomon E., Whitehouse C., Gautel M. Interactions with LC3 and polyubiquitin chains link nbr1 to autophagic protein turnover. FEBS Lett. 2009;583:1846&#x2013;1852. doi: 10.1016/j.febslet.2009.04.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2009.04.049</ArticleId><ArticleId IdType="pubmed">19427866</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Raasi S., Fushman D. Affinity makes the difference: nonselective interaction of the UBA domain of Ubiquilin-1 with monomeric ubiquitin and polyubiquitin chains. J. Mol. Biol. 2008;377:162&#x2013;180. doi: 10.1016/j.jmb.2007.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2007.12.029</ArticleId><ArticleId IdType="pmc">PMC2323583</ArticleId><ArticleId IdType="pubmed">18241885</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson K.A., Hicke L., Radhakrishnan I. Structural basis for monoubiquitin recognition by the Ede1 UBA domain. J. Mol. Biol. 2006;358:713&#x2013;724. doi: 10.1016/j.jmb.2006.02.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2006.02.059</ArticleId><ArticleId IdType="pubmed">16563434</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Xu D., Wang Y., Zhou Z., Liu J., Hu S., Gong Y., Yuan J., Pan L. Structural insights into the ubiquitin recognition by OPTN (optineurin) and its regulation by TBK1-mediated phosphorylation. Autophagy. 2018;14:66&#x2013;79. doi: 10.1080/15548627.2017.1391970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1391970</ArticleId><ArticleId IdType="pmc">PMC5846504</ArticleId><ArticleId IdType="pubmed">29394115</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleason C.E., Ordureau A., Gourlay R., Arthur J.S., Cohen P. Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon &#x3b2;. J. Biol. Chem. 2011;286:35663&#x2013;35674. doi: 10.1074/jbc.M111.267567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.267567</ArticleId><ArticleId IdType="pmc">PMC3195586</ArticleId><ArticleId IdType="pubmed">21862579</ArticleId></ArticleIdList></Reference><Reference><Citation>Korac J., Schaeffer V., Kovacevic I., Clement A.M., Jungblut B., Behl C., Terzic J., Dikic I. Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J. Cell Sci. 2013;126:580&#x2013;592. doi: 10.1242/jcs.114926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.114926</ArticleId><ArticleId IdType="pmc">PMC3654196</ArticleId><ArticleId IdType="pubmed">23178947</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X., Li F., Wang Y., Lin Z., Cheng X., Liu J., Chen C., Pan L. Molecular basis of ubiquitin recognition by the autophagy receptor CALCOCO2. Autophagy. 2015;11:1775&#x2013;1789. doi: 10.1080/15548627.2015.1082025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1082025</ArticleId><ArticleId IdType="pmc">PMC4824588</ArticleId><ArticleId IdType="pubmed">26506893</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Muhlinen N., Thurston T., Ryzhakov G., Bloor S., Randow F. NDP52, a novel autophagy receptor for ubiquitin-decorated cytosolic bacteria. Autophagy. 2010;6:288&#x2013;289. doi: 10.4161/auto.6.2.11118.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.6.2.11118</ArticleId><ArticleId IdType="pubmed">20104023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarou M., Sliter D.A., Kane L.A., Sarraf S.A., Wang C., Burman J.L., Sideris D.P., Fogel A.I., Youle R.J. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524:309&#x2013;314. doi: 10.1038/nature14893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14893</ArticleId><ArticleId IdType="pmc">PMC5018156</ArticleId><ArticleId IdType="pubmed">26266977</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul P.K., Kumar A. TRAF6 coordinates the activation of autophagy and ubiquitin&#x2013;proteasome systems in atrophying skeletal muscle. Autophagy. 2011;7:555&#x2013;556. doi: 10.4161/auto.7.5.15102.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.7.5.15102</ArticleId><ArticleId IdType="pmc">PMC3127217</ArticleId><ArticleId IdType="pubmed">21412053</ArticleId></ArticleIdList></Reference><Reference><Citation>Walinda E., Morimoto D., Sugase K., Konuma T., Tochio H., Shirakawa M. Solution structure of the ubiquitin-associated (UBA) domain of human autophagy receptor NBR1 and its interaction with ubiquitin and polyubiquitin. J. Biol. Chem. 2014;289:13890&#x2013;13902. doi: 10.1074/jbc.M114.555441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.555441</ArticleId><ArticleId IdType="pmc">PMC4022861</ArticleId><ArticleId IdType="pubmed">24692539</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Mart&#xed;n P., Komatsu M. p62/SQSTM1&#x2014;Steering the cell through health and disease. J. Cell Sci. 2018;131 doi: 10.1242/jcs.222836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.222836</ArticleId><ArticleId IdType="pubmed">30397181</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichimura Y., Waguri S., Sou Y.S., Kageyama S., Hasegawa J., Ishimura R., Saito T., Yang Y., Kouno T., Fukutomi T., et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol. Cell. 2013;51:618&#x2013;631. doi: 10.1016/j.molcel.2013.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.08.003</ArticleId><ArticleId IdType="pubmed">24011591</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild P., Farhan H., McEwan D.G., Wagner S., Rogov V.V., Brady N.R., Richter B., Korac J., Waidmann O., Choudhary C., et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science. 2011;333:228&#x2013;233. doi: 10.1126/science.1205405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1205405</ArticleId><ArticleId IdType="pmc">PMC3714538</ArticleId><ArticleId IdType="pubmed">21617041</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicot A.S., Lo Verso F., Ratti F., Pilot-Storck F., Streichenberger N., Sandri M., Schaeffer L., Goillot E. Phosphorylation of NBR1 by GSK3 modulates protein aggregation. Autophagy. 2014;10:1036&#x2013;1053. doi: 10.4161/auto.28479.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.28479</ArticleId><ArticleId IdType="pmc">PMC4091167</ArticleId><ArticleId IdType="pubmed">24879152</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z., Purtell K., Lachance V., Wold M.S., Chen S., Yue Z. Autophagy Receptors and Neurodegenerative Diseases. Trends Cell Biol. 2017;27:491&#x2013;504. doi: 10.1016/j.tcb.2017.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2017.01.001</ArticleId><ArticleId IdType="pubmed">28169082</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinsztein D.C., Nixon R.A. Rapamycin induces autophagic flux in neurons. Proc. Natl. Acad. Sci. USA. 2010;107:E181. doi: 10.1073/pnas.1014633107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1014633107</ArticleId><ArticleId IdType="pmc">PMC3000262</ArticleId><ArticleId IdType="pubmed">21115811</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger Z., Ravikumar B., Menzies F.M., Oroz L.G., Underwood B.R., Pangalos M.N., Schmitt I., Wullner U., Evert B.O., O&#x2019;Kane C.J., et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum. Mol. Genet. 2006;15:433&#x2013;442. doi: 10.1093/hmg/ddi458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddi458</ArticleId><ArticleId IdType="pubmed">16368705</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y., Tatebe H., Taguchi K., Endo Y., Tokuda T., Mizuno T., Nakagawa M., Tanaka M. p62/SQSTM1-dependent autophagy of Lewy body-like &#x3b1;-synuclein inclusions. PLoS ONE. 2012;7:e52868. doi: 10.1371/journal.pone.0052868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052868</ArticleId><ArticleId IdType="pmc">PMC3534125</ArticleId><ArticleId IdType="pubmed">23300799</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Chen S., Song L., Tang Y., Shen Y., Jia L., Le W. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis. Autophagy. 2014;10:588&#x2013;602. doi: 10.4161/auto.27710.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.27710</ArticleId><ArticleId IdType="pmc">PMC4091147</ArticleId><ArticleId IdType="pubmed">24441414</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaeffer V., Goedert M. Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy. Autophagy. 2012;8:1686&#x2013;1687. doi: 10.4161/auto.21488.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.21488</ArticleId><ArticleId IdType="pmc">PMC3494601</ArticleId><ArticleId IdType="pubmed">22874558</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura S., Oba M., Suzuki M., Takahashi A., Yamamuro T., Fujiwara M., Ikenaka K., Minami S., Tabata N., Yamamoto K., et al. Suppression of autophagic activity by Rubicon is a signature of aging. Nat. Commun. 2019;10:847. doi: 10.1038/s41467-019-08729-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-08729-6</ArticleId><ArticleId IdType="pmc">PMC6381146</ArticleId><ArticleId IdType="pubmed">30783089</ArticleId></ArticleIdList></Reference><Reference><Citation>Park D., Jeong H., Lee M.N., Koh A., Kwon O., Yang Y.R., Noh J., Suh P.G., Park H., Ryu S.H. Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition. Sci. Rep. 2016;6:21772. doi: 10.1038/srep21772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep21772</ArticleId><ArticleId IdType="pmc">PMC4763238</ArticleId><ArticleId IdType="pubmed">26902888</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner R.S., Thomas R.G., Craft S., van Dyck C.H., Mintzer J., Reynolds B.A., Brewer J.B., Rissman R.A., Raman R., Aisen P.S. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology. 2015;85:1383&#x2013;1391. doi: 10.1212/WNL.0000000000002035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002035</ArticleId><ArticleId IdType="pmc">PMC4626244</ArticleId><ArticleId IdType="pubmed">26362286</ArticleId></ArticleIdList></Reference><Reference><Citation>Cano-Cuenca N., Sol&#xed;s-Garc&#xed;a del Pozo J.E., Jord&#xe1;n J. Evidence for the efficacy of latrepirdine (Dimebon) treatment for improvement of cognitive function: A meta-analysis. J. Alzheimer&#x2019;s Dis. 2014;38:155&#x2013;164. doi: 10.3233/JAD-130872.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-130872</ArticleId><ArticleId IdType="pubmed">23948924</ArticleId></ArticleIdList></Reference><Reference><Citation>Koenig A.M., Mechanic-Hamilton D., Xie S.X., Combs M.F., Cappola A.R., Xie L., Detre J.A., Wolk D.A., Arnold S.E. Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study. Alzheimer Dis. Assoc. Disord. 2017;31:107&#x2013;113. doi: 10.1097/WAD.0000000000000202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0000000000000202</ArticleId><ArticleId IdType="pmc">PMC5476214</ArticleId><ArticleId IdType="pubmed">28538088</ArticleId></ArticleIdList></Reference><Reference><Citation>Suresh S.N., Chakravorty A., Giridharan M., Garimella L., Manjithaya R. Pharmacological Tools to Modulate Autophagy in Neurodegenerative Diseases. J. Mol. Biol. 2020;432:2822&#x2013;2842. doi: 10.1016/j.jmb.2020.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2020.02.023</ArticleId><ArticleId IdType="pubmed">32105729</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim K.H., Joo J.Y., Baek K.H. The potential roles of deubiquitinating enzymes in brain diseases. Ageing Res. Rev. 2020;61:101088. doi: 10.1016/j.arr.2020.101088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2020.101088</ArticleId><ArticleId IdType="pubmed">32470641</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>